Date Received: 26-02-2025
Date Published: 21-03-2025
##submissions.doi##: https://doi.org/10.1234/zcpdqf98
Views
Downloads
How to Cite:
Some Pathological Features of Cutaneous and Subcutaneous Mast Cell Tumors in Dogs
Keywords
Dog, histopathology, mast cell, tumor, skin
Abstract
Mast cell tumors commonly occur in the skin of dogs. This study provided information on the clinical features, and gross and histological lesions of the canine mast cell tumors so as to serve for diagnosis and treatment. The research investigated 8 dogs from 7 to 11 years old. The dogs were diagnosed with mast cell tumors shoing symptoms such as solitary nodules, swelling, ulcer, and haemorrhage in the skin. The result of examining histopathology showed that mast cell tumor includes two types: cutaneous and subcutaneous mast cell tumors in which subcutaneous mast cell tumor was worse than cutaneous mast cell tumor in prognosis.
References
D’mello A.X.P., Sylvester T.V., Ramya V., Britto F.P., Shetty P.K. & Jasphin S. (2016). Metachromasia and metachromatic dyes: A review.
International Journal of Advanced Health Sciences. 2(10): 12-17.
de Nardi A.B., Dos Santos H.R., Fonseca-Alves C.E., de Paiva F.N…, Grandi F., Matera J.M., Vozdova M. & Dagli M.L.Z. (2022). Diagnosis, prognosis and treatment of canine cutaneous and subcutaneous mast cell tumors. Cells. 11(4):618.
de Strefezzi R.F., Xavier J.G., Kleeb S.R. & Catão-Dias J.L. (2009). Nuclear morphometry in cytopathology: a prognostic indicator for canine cutaneous mast cell tumors. Journal of Veterinary Diagnostic Investigation. 21(6): 821-825.
Duncan J.R. & Prasse K.W. (1979). Cytology of canine cutaneous round cell tumors. Mast cell
tumor, histiocytoma, lymphosarcoma and transmissible venereal tumor. Veterinary Pathology. 16(6): 673-679.
Egozi E.I., Ferreira A.M., Burns A.L., Gamelli R.L. & Dipietro L.A. (2003). Mast cells modulate the inflammatory but not the proliferative response in healing wounds. Wound Repair and Regeneration. 11(1): 46-54.
Goldschmidt M.H. (2002). "Tumors of the skin and soft tissues" in Tumors in domestic animals. pp. 45-117.
Hoffmann H.J., Frandsen P.M., Christensen L.H., Schiøtz P.O. & Dahl R. (2012). Cultured human mast cells are heterogeneous for expression of the high-affinity IgE receptor FcåRI. International Archives of Allergy and Immunology. 157(3): 246-250.
Kiupel M. (2016). “Mast cell tumor” in Tumors in domestic animals. pp. 176-200.
Kiupel M., Webster J.D. & Miller R. (2011). Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior. Veterinary Pathology. 48(1): 147-155.
Kiupel M. & Camus M. (2019). Diagnosis and prognosis of canine cutaneous mast cell tumors. The Veterinary clinics of North America. Small Animal Practice. 49(5): 819-836.
Krick E.L., Billings A.P., Shofer F.S., Watanabe S. & Sorenmo K.U. (2009). Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival. Veterinary and Comparative Oncology. 7(2): 130-138.
Mochizuki H., Motsinger-Reif A., Bettini C., Moroff S. & Breen M. (2017). Association of breed and histopathological grade in canine mast cell tumours. Veterinary and Comparative Oncology. 15(3): 829-839.
Oliveira F.N., Elliott J.W., Lewis B.C., Mathews G.G., Brown R.M., Treadway C.M. & Langohr I.M. (2013). Cutaneous mast cell tumor with epitheliotropism in 3 dogs. Veterinary Pathology. 50(2): 234-237.
Patnaik A.K., Ehler W.J. & MacEwen E.G. (1984). Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Veterinary Pathology. 21(5): 469-474.
Reynolds B.D., Thomson M.J., O'Connell K., Morgan E.J. & Gummow, B. (2019). Patient and tumour factors influencing canine mast cell tumour histological grade and mitotic index. Veterinary and Comparative Oncology. 17(3): 338-344.
Rothwell T.L., Howlett C.R., Middleton D.J., Griffiths D.A. & Duff B.C. (1987). Skin neoplasms of dogs in Sydney. Australian Veterinary Journal.
(6): 161-164.
Sabattini, S., Scarpa F., Berlato D. & Bettini G. (2015). Histologic grading of canine mast cell tumor: is 2 better than 3?. Veterinary Pathology. 52(1): 70-73.
Simoes J.P. & Schoning P. (1994). Canine mast cell tumors: a comparison of staining techniques. Journal of Veterinary Diagnostic Investigation. 6(4): 458-465.
Sledge D.G., Webster J. & Kiupel M. (2016). Canine cutaneous mast cell tumors: A combined clinical and pathologic approach to diagnosis, prognosis,
and treatment selection. Veterinary Journal.
: 43-54.
Śmiech A., Ślaska B., Łopuszyński W., Jasik A., Bochyńska D. & Dąbrowski R. (2018). Epidemiological assessment of the risk of canine mast cell tumours based on the Kiupel two-grade malignancy classification. Acta Veterinaria Scandinavica. 60(1): 70.
Strafuss A.C. (1985). Skin tumors. The Veterinary clinics of North America. Small Animal Practice. 15(3): 473-492.
Thangam E.B., Jemima E.A., Singh H., Baig M.S., Khan M., Mathias C.B., Church M.K. & Saluja R. (2018). The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: The hunt for new therapeutic targets. Frontiers in Immunology. 9: 1873.
Thompson J.J., Pearl D.L., Yager J.A., Best S.J., Coomber B.L. & Foster R.A. (2011). Canine subcutaneous mast cell tumor: characterization and prognostic indices. Veterinary Pathology.
(1): 156-168.
Trentin B.S., Demasi A.P., Fantelli Stelini R., Cintra M.L., Cavalcanti de Araujo V. & Borges Soares A. (2019). Endoglin is highly expressed in human mast cells. Applied Immunohistochemistry & Molecular Morphology. 27(8): 613-617.
Villamil J.A., Henry C.J., Bryan J.N., Ellersieck M., Schultz L., Tyler J.W. & Hahn A.W. (2011). Identification of the most common cutaneous neoplasms in dogs and evaluation of breed and age distributions for selected neoplasms. Journal of the American Veterinary Medical Association.
(7): 960-965.
Weishaar K.M., Thamm D.H., Worley D.R. & Kamstock D.A. (2014). Correlation of nodal mast cells with clinical outcome in dogs with mast cell tumour and a proposed classification system for the evaluation of node metastasis. Journal of Comparative Pathology. 151(4): 329-338.